By: Marie Chesaniuk & Lisa Henderson | Published: April 13, 2017
By: Gina Kruse MD, MS, MPH, and Jamie S. Ostroff, PhD | Published: April 10, 2015
Electronic cigarettes have been labeled a disruptive technology resulting in much speculation as to whether they are likely to help or hinder efforts to reduce tobacco-related morbidity and mortality. Awareness of e-cigarettes has increased dramatically and public perceptions of their harmfulness vary. E-cigarette adoption has far outpaced knowledge of the actual harms and benefits, making informed discussion difficult for consumers, clinicians, and scientists alike.
By: Emily G. Lattie, MS, SBM Digital Health Council member | Published: March 27, 2015
Commercial applications that function as diagnostic tools or that control the function of existing medical devices are up for regulation, while most applications based in behavioral medicine will continue to be generally exempt from FDA regulation.
By: Wendy J. Nilsen, PhD, OBSSR health scientist administrator | Published: February 19, 2015
Moving mHealth forward will involve understanding behavior, including not only the factors driving health behaviors, but also the mediators and moderators of everyday activities and decisions. With this broad knowledge of user and health, we can bring in experts specializing in user experience, human-computer interaction and other human factors disciplines who will partner with health and technology experts to create mHealth tools that improve health outcomes. Based on our best science, these tools will fit into people’s lives and be useful.
By: SBM Obesity and Eating Disorders Special Interest Group Co-Chair Stephanie L. Fitzpatrick, PhD | Published: December 11, 2014
The current reimbursement policies for behavioral health services are not aligned with the established evidence in the literature.
By: Sherri Sheinfeld Gorin, PhD | Published: November 10, 2014
Behavioral medicine professionals have expertise to contribute to the current Ebola outbreak.
By: SBM Digital Health Council Chair Ellen Beckjord, PhD, MPH | Published: October 3, 2014
In the guidance on using social media to present risk and benefit information, there is concern that social media platforms with character space limitations pose a challenge to the feasibility of balancing the presentation of benefits and risks associated with drugs and devices in the communication. In the guidance on using social media to correct misinformation, the FDA is concerned with content created by manufacturers or distributors of drugs or medical devices in response to unaffiliated, third-party user-generated content about drugs and medical devices on social media which may contain misinformation about a drug or medical device.
By: Society of Behavioral Medicine | Published: September 10, 2014
Chief among those questions is whether or not such a fundraising effort is repeatable or sustainable.
By: Society of Behavioral Medicine | Published: August 13, 2014
The U.S. surgeon general on July 29 released a call to action on preventing skin cancer. The call to action specifically says indoor tanning is harmful. It also says shade opportunities must be increased in recreational settings and skin cancer prevention should be taught in schools and even during workplace trainings, among other recommendations.
By: Ellen Beckjord, PhD, MPH | Published: June 3, 2014
The strategic planning priorities point to moving SBM toward being a professional society that has a leadership role in: setting the standards for behavioral health care; supporting its members to secure funding for their work; and executing and disseminating innovative research that emphasizes the ever-increasing role of technology in behavioral medicine.